Opportunity ID: 250758

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DA-15-003
Funding Opportunity Title: Medications Development Centers of Excellence Cooperative Program (U54)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards: 2
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jan 31, 2014
Last Updated Date:
Original Closing Date for Applications: Apr 25, 2014
Current Closing Date for Applications: Apr 25, 2014
Archive Date: May 26, 2014
Estimated Total Program Funding: $3,000,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Special district governments
City or township governments
Private institutions of higher education
Public and State controlled institutions of higher education
County governments
Public housing authorities/Indian housing authorities
State governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Native American tribal governments (Federally recognized)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This FOA solicits Specialized Center Cooperative Agreement (U54) applications to provide support for Medications Development Centers of Excellence (MDCE) with emphasis solely on clinical research directed towards the identification, evaluation, and development of safe and effective medications and biologics for treatment of substance use disorders (SUDs). Research may focus on both currently approved or novel investigational products. Centers may have a translational project to reinforce rationale of medications for testing. Any preclinical work proposed must be specifically devoted to the reinforcement of rationale of medications planned for clinical testing during the life of the project.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-15-003.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

2025-07-09T08:37:42-05:00

Share This Post, Choose Your Platform!

About the Author: